Moderna co-founder sees debut T.Rx Capital fund reach $77.5m final close

T.Rx Capital, a new venture capital firm launched by a team including pharma and biotech giant Moderna's co-founder Michael Langer, has closed its debut early-stage healthcare innovation fund on $77.5m.